SQA
CLGN icon

Simon Quick Advisors’s CollPlant Biotechnologies CLGN Stock Holding History

Simon Quick Advisors’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,202
Closed -$92.7K – 287
2023
Q1 		$92.7K Sell
13,202
-2,474
-16% -$24.3K 0.01% 270
2022
Q4 		$131K Hold
15,676
– – 0.02% 229
2022
Q3 		$107K Hold
15,676
– – 0.02% 190
2022
Q2 		$139K Buy
+15,676
New +$144K 0.02% 165

Other funds holding CLGN

RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BFEC
Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Simon Quick Advisors's CLGN Position: Q2 2023 in Review

Simon Quick Advisors sold out of CollPlant Biotechnologies (CLGN) in Q2 2023, closing a stake of 13,202 shares — an estimated $92.7K sold.

Simon Quick Advisors first reported a position in CLGN in Q2 2022 and held it in 4 quarters. The position peaked at $139K in Q2 2022. 17 funds tracked by Wall St. Rank hold CLGN as of Q2 2023.

  • Simon Quick Advisors reported no remaining CollPlant Biotechnologies position as of Q2 2023 after selling out during the quarter.
  • Simon Quick Advisors sold 13,202 CollPlant Biotechnologies shares in Q2 2023, an estimated $92.7K.
  • Simon Quick Advisors first reported a position in CollPlant Biotechnologies in Q2 2022 and held it in 4 quarters.
  • Simon Quick Advisors's CollPlant Biotechnologies position peaked at $139K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2023.

Based on Simon Quick Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.